Found 1 document(s)
Page 1 of 1
-
Abstract The cyclooxygenase-2 (COX-2) receptor is a therapeutic target for the development of potential drugs with anti-inflammatory activity. Rofecoxib, one of the first selective COX-2 inhibitors (coxibs), was approved...